title: Botulinum toxin in the treatment of tardive dystonia.
authors.forename: A
authors.initials: A
authors.lastname: Chatterjee
authors.forename: M
authors.initials: M
authors.lastname: Forrest Gordon
authors.forename: N
authors.initials: N
authors.lastname: Giladi
authors.forename: R
authors.initials: R
authors.lastname: Trosch
mesh_terms: D000328:Adult; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D018492:Dopamine Antagonists / Q000009:adverse effects; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009465:Neuromuscular Agents / Q000627:therapeutic use*; D012189:Retrospective Studies
chemical_list: D018492:Dopamine Antagonists; D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A